William Rose - Jun 8, 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director, Member of 10% owner group, 10%+ Owner
Signature
/s/ Charles E. Gale, attorney-in-fact for William E. Rose
Stock symbol
RETA
Transactions as of
Jun 8, 2022
Transactions value $
$79,987
Form type
4
Date filed
6/10/2022, 04:30 PM
Previous filing
Jun 14, 2021
Next filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right-to-buy) Award $0 +11.2K $0.00 11.2K Jun 8, 2022 Class A common stock 11.2K $34.76 Direct F1
transaction RETA Stock Option (right-to-buy) Award $80K +3.33K $24.02* 3.33K Jun 8, 2022 Class A common stock 3.33K $34.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023 and June 7, 2023, subject to continued service through each vesting date.
F2 These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $80,000.